The short version
- French authorities have confirmed the first known human infection of Shamonda virus, which was detected in a patient with a compromised immune system who subsequently died.
- The virus is primarily transmitted to livestock by biting midges and causes symptoms such as diarrhea and reproductive issues in animals, but its effects on healthy humans remain unknown.
- Experts state that the risk to the general public is currently very low, with no evidence of sustained human-to-human transmission or widespread threat.
French health officials have confirmed the detection of Shamonda virus in a human for the first time, marking an unusual breach of the species barrier for a pathogen previously known only to infect livestock. The case involves a man treated in Lyon who was already suffering from a serious illness and had a severely compromised immune system. He died in early October, prompting investigations into whether the viral infection contributed to his death or merely coincided with it.
The European Centre for Disease Prevention and Control identified this patient as the first recognized human case of the bunyavirus. While the virus has been circulating among animals in Europe since the summer, its presence in a human host is unprecedented. French authorities have notified international health bodies, including the World Health Organization, to coordinate surveillance and assess any broader implications for public health safety.
Shamonda virus is transmitted through the bites of infected midges. In animal populations, particularly cattle, sheep, goats, and horses, the pathogen can cause gastrointestinal distress, reduced appetite, and significant declines in milk production. It has also been linked to abortions and congenital abnormalities in newborn livestock. Genetic material from the virus has even been found in the brains of horses that died from neurological symptoms in Switzerland and Germany, suggesting a potential for severe complications in certain species.
The patient in France was likely exposed to the virus through a midge bite in eastern France, where the pathogen was reported to be circulating among animal populations during the spring and summer months. The virus was first detected in Nigeria in the mid-1960s and has since been reported sporadically in cattle across West, East, and Southern Africa, as well as in Japan. Its appearance in European livestock this summer marked a new geographic expansion of the pathogen.
Because the patient had a weakened immune system, it remains unclear whether the virus played a direct role in his death or if he succumbed to his underlying conditions. French authorities believe that neurological complications observed in the patient were very likely linked to the infection, but this connection is still under investigation. The uncertainty surrounding the cause of death highlights the challenges in determining the pathogenicity of newly identified human infections.
Experts emphasize that the risk to the general public appears to be very low. Professor Tom Solomon, director of the pandemic institute at the University of Liverpool, noted that while the virus has circulated in animals for many years, transmission to humans is extremely unusual. He pointed out that one exceptional case does not necessarily indicate a significant threat to the wider population, especially given the lack of evidence for sustained human-to-human transmission.
Dr. Ben Brennan from the MRC-University of Glasgow’s centre for virus research echoed these sentiments, stating that there is currently no reason for most people to change their normal activities or take additional precautions. He described the discovery as warranting further scientific investigation and continued surveillance but not suggesting a significant new public health threat to countries like the UK.
Despite the low immediate risk, significant unknowns remain regarding how the virus behaves in healthy humans. Scientists do not yet know whether individuals with robust immune systems can become infected without developing symptoms, what specific symptoms the virus might normally cause in such cases, or how frequently it might lead to serious disease. These gaps in knowledge underscore the need for ongoing monitoring and research.
The case serves as a reminder of the complex interactions between animal health and human safety. As climate patterns shift and animal populations move, the potential for zoonotic spillover events may increase. Health authorities are likely to enhance surveillance of both livestock and human populations in areas where the virus is present among animals to detect any future cases early.
For now, the focus remains on understanding the specific circumstances of this French case. Investigations into how the infection was acquired and whether it contributed to the patient's death are ongoing. Until more data emerges, public health guidance will likely remain centered on standard precautions against insect bites rather than widespread alarm or restrictive measures.
Sources behind this briefing
Go to the original reporting
- The Guardian World↗Shamonda virus detected in human for first time in France
- PBS NewsHour↗France reports first human case of livestock virus Shamonda in patient who later died
